Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis.
Dermatomyositis (DM) patients might present with pulmonary involvement as the first manifestation or during the follow-up period. It is sometimes difficult to determine whether the clinical manifestations related with pulmonary involvement are due to DM or to an infectious process. We report a case of DM patient who developed interstitial pneumonitis induced by cytomegalovirus (CMV) while receiving immunosuppressive treatment. To the best of our knowledge, this is the second report in the literature of interstitial pneumonitis secondary to CMV infection in a patient with DM.
Kaşifoğlu
Timuçin
T
Division of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University Medical Faculty, Eskişehir, Turkey.
Korkmaz
Cengiz
C
Ozkan
Ragip
R
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D003587:Cytomegalovirus / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011024:Pneumonia, Viral / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011239:Prednisolone / Q000009:adverse effects; D013902:Radiography, Thoracic; D016896:Treatment Outcome
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine